| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | BIOCORRX INC. | 2390 EAST ORANGEWOOD AVE | ANAHEIM | CA | 92806-6139 | ORANGE | USA | UH3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 000 | 3 | NIH | 3/13/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | BIOCORRX INC. | 2390 EAST ORANGEWOOD AVE | ANAHEIM | CA | 92806 | ORANGE | USA | UH3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 000 | 3 | NIH | 2/24/2023 | $0 |
| | 2023 | 2021 | BIOCORRX INC. | 2390 EAST ORANGEWOOD AVE | ANAHEIM | CA | 92806-6139 | ORANGE | USA | UH3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 001 | 3 | NIH | 9/26/2023 | $0 |
| | 2023 | 2020 | BIOCORRX INC. | 2390 EAST ORANGEWOOD AVE | ANAHEIM | CA | 92806-6139 | ORANGE | USA | UG3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 000 | 2 | NIH | 11/13/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $99,431 ) |
| | 2022 | 2022 | BIOCORRX INC. | 2390 E ORANGEWOOD AVE STE 575 | ANAHEIM | CA | 92806-6184 | ORANGE | USA | UH3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 000 | 3 | NIH | 3/31/2022 | $99,431 |
|
| Issue Date FY: 2021 ( Subtotal = $3,453,367 ) |
| | 2021 | 2021 | BIOCORRX INC. | 2390 E ORANGEWOOD AVE STE 575 | ANAHEIM | CA | 92806-6184 | ORANGE | USA | UH3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 000 | 3 | NIH | 8/27/2021 | $3,453,367 |
| | 2021 | 2020 | BIOCORRX INC. | 2390 E ORANGEWOOD AVE STE 575 | ANAHEIM | CA | 92806-6184 | ORANGE | USA | UG3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 001 | 2 | NIH | 5/27/2021 | $0 |
| | 2021 | 2020 | BIOCORRX INC. | 2390 E ORANGEWOOD AVE STE 575 | ANAHEIM | CA | 92806-6184 | ORANGE | USA | UG3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 000 | 2 | NIH | 1/12/2021 | $0 |
| | 2021 | 2020 | BIOCORRX INC. | 2390 E ORANGEWOOD AVE STE 575 | ANAHEIM | CA | 92806-6184 | ORANGE | USA | UG3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 002 | 2 | NIH | 8/26/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $2,831,838 ) |
| | 2020 | 2020 | BIOCORRX INC. | 2390 E ORANGEWOOD AVE STE 575 | ANAHEIM | CA | 92806-6184 | ORANGE | USA | UG3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 000 | 2 | NIH | 1/28/2020 | $2,831,838 |
| | 2020 | 2020 | BIOCORRX INC. | 2390 E ORANGEWOOD AVE STE 575 | ANAHEIM | CA | 92806-6184 | ORANGE | USA | UG3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 001 | 2 | NIH | 8/25/2020 | $0 |
| | 2020 | 2020 | BIOCORRX INC. | 2390 E ORANGEWOOD AVE STE 575 | ANAHEIM | CA | 92806-6184 | ORANGE | USA | UG3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 002 | 2 | NIH | 9/10/2020 | -$2,831,838 |
| | 2020 | 2020 | BIOCORRX INC. | 2390 E ORANGEWOOD AVE STE 575 | ANAHEIM | CA | 92806-6184 | ORANGE | USA | UG3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 002 | 2 | NIH | 9/10/2020 | $2,831,838 |
|
| Issue Date FY: 2019 ( Subtotal = $2,842,430 ) |
| | 2019 | 2019 | BIOCORRX INC. | 2390 E ORANGEWOOD AVE STE 575 | ANAHEIM | CA | 92806-6184 | ORANGE | USA | UG3DA047925 | Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder. | 000 | 1 | NIH | 1/17/2019 | $2,842,430 |
|
|
